5-[(2S)-4-[(3-ethyl-2,4-dioxo-1H-quinazolin-7-yl)methyl]-2-methylpiperazin-1-yl]-N-methylpyridine-2-carboxamide

C23H28N6O3 — CID 170981529

IUPAC5-[(2S)-4-[(3-ethyl-2,4-dioxo-1H-quinazolin-7-yl)methyl]-2-methylpiperazin-1-yl]-N-methylpyridine-2-carboxamide
SMILESCCn1c(=O)[nH]c2cc(CN3CCN(c4ccc(C(=O)NC)nc4)[C@@H](C)C3)ccc2c1=O
InChIInChI=1S/C23H28N6O3/c1-4-28-22(31)18-7-5-16(11-20(18)26-23(28)32)14-27-9-10-29(15(2)13-27)17-6-8-19(25-12-17)21(30)24-3/h5-8,11-12,15H,4,9-10,13-14H2,1-3H3,(H,24,30)(H,26,32)/t15-/m0/s1
InChIKeyFMRFPEPLXOZKPJ-HNNXBMFYSA-N
MW436.52 g/mol
LogP1.17
Rot. Bonds5

About 5-[(2S)-4-[(3-ethyl-2,4-dioxo-1H-quinazolin-7-yl)methyl]-2-methylpiperazin-1-yl]-N-methylpyridine-2-carboxamide

5-[(2S)-4-[(3-ethyl-2,4-dioxo-1H-quinazolin-7-yl)methyl]-2-methylpiperazin-1-yl]-N-methylpyridine-2-carboxamide (PubChem CID 170981529) has the molecular formula C23H28N6O3 and a molecular weight of 436.52 g/mol. Its IUPAC name is 5-[(2S)-4-[(3-ethyl-2,4-dioxo-1H-quinazolin-7-yl)methyl]-2-methylpiperazin-1-yl]-N-methylpyridine-2-carboxamide.

Molecular Properties

Compound Name5-[(2S)-4-[(3-ethyl-2,4-dioxo-1H-quinazolin-7-yl)methyl]-2-methylpiperazin-1-yl]-N-methylpyridine-2-carboxamide
PubChem CID170981529
Molecular FormulaC23H28N6O3
Molecular Weight436.52 g/mol
Exact Mass436.22
IUPAC Name5-[(2S)-4-[(3-ethyl-2,4-dioxo-1H-quinazolin-7-yl)methyl]-2-methylpiperazin-1-yl]-N-methylpyridine-2-carboxamide
SMILESCCn1c(=O)[nH]c2cc(CN3CCN(c4ccc(C(=O)NC)nc4)[C@@H](C)C3)ccc2c1=O
InChIInChI=1S/C23H28N6O3/c1-4-28-22(31)18-7-5-16(11-20(18)26-23(28)32)14-27-9-10-29(15(2)13-27)17-6-8-19(25-12-17)21(30)24-3/h5-8,11-12,15H,4,9-10,13-14H2,1-3H3,(H,24,30)(H,26,32)/t15-/m0/s1
InChIKeyFMRFPEPLXOZKPJ-HNNXBMFYSA-N
XLogP1.17
TPSA103.33 Ų
H-Bond Donors2
H-Bond Acceptors7
Rotatable Bonds5
Heavy Atoms32
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500436.52
LogP ≤ 51.17
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 107

Analyze 5-[(2S)-4-[(3-ethyl-2,4-dioxo-1H-quinazolin-7-yl)methyl]-2-methylpiperazin-1-yl]-N-methylpyridine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-[(2S)-4-[(3-ethyl-2,4-dioxo-1H-quinazolin-7-yl)methyl]-2-methylpiperazin-1-yl]-N-methylpyridine-2-carboxamide?
The IUPAC name of 5-[(2S)-4-[(3-ethyl-2,4-dioxo-1H-quinazolin-7-yl)methyl]-2-methylpiperazin-1-yl]-N-methylpyridine-2-carboxamide (CID 170981529) is 5-[(2S)-4-[(3-ethyl-2,4-dioxo-1H-quinazolin-7-yl)methyl]-2-methylpiperazin-1-yl]-N-methylpyridine-2-carboxamide.
What is the SMILES notation for 5-[(2S)-4-[(3-ethyl-2,4-dioxo-1H-quinazolin-7-yl)methyl]-2-methylpiperazin-1-yl]-N-methylpyridine-2-carboxamide?
The canonical SMILES for 5-[(2S)-4-[(3-ethyl-2,4-dioxo-1H-quinazolin-7-yl)methyl]-2-methylpiperazin-1-yl]-N-methylpyridine-2-carboxamide is CCn1c(=O)[nH]c2cc(CN3CCN(c4ccc(C(=O)NC)nc4)[C@@H](C)C3)ccc2c1=O.
What is the InChIKey of 5-[(2S)-4-[(3-ethyl-2,4-dioxo-1H-quinazolin-7-yl)methyl]-2-methylpiperazin-1-yl]-N-methylpyridine-2-carboxamide?
The InChIKey is FMRFPEPLXOZKPJ-HNNXBMFYSA-N. The full InChI is InChI=1S/C23H28N6O3/c1-4-28-22(31)18-7-5-16(11-20(18)26-23(28)32)14-27-9-10-29(15(2)13-27)17-6-8-19(25-12-17)21(30)24-3/h5-8,11-12,15H,4,9-10,13-14H2,1-3H3,(H,24,30)(H,26,32)/t15-/m0/s1.
What are the key properties of 5-[(2S)-4-[(3-ethyl-2,4-dioxo-1H-quinazolin-7-yl)methyl]-2-methylpiperazin-1-yl]-N-methylpyridine-2-carboxamide?
5-[(2S)-4-[(3-ethyl-2,4-dioxo-1H-quinazolin-7-yl)methyl]-2-methylpiperazin-1-yl]-N-methylpyridine-2-carboxamide has a molecular weight of 436.52 g/mol, XLogP of 1.17, 5 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[(2S)-4-[(3-ethyl-2,4-dioxo-1H-quinazolin-7-yl)methyl]-2-methylpiperazin-1-yl]-N-methylpyridine-2-carboxamide is sourced from PubChem (CID 170981529), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).